ARCHIVES

FDA Authority To Remove Paclitaxel Patent Questioned.

This article is from The Cancer Letter archive.

Vol. 27 No. 06 | February 9, 2001

Download PDF Visit The Full Archive

Related Articles

Wender Named ACS Chief Cancer Control Officer

August 9, 2013

Some Long-Term Survivors At Higher Risk Of Stroke

November 24, 2006

ODAC Votes for Marqibo Accelerated Approval

March 30, 2012

NIH Bias Against Young Investigators Threatens To “Deprime The Pump,” Zerhouni Says.

February 15, 2008

November issue of Business & Regulatory Report, an additional 8 pages, included in this issue.

November 19, 2004

NCI Announces New Grant Programs In Preventions, Smoking, Alcohol; 1980 Applications Due March 1

January 11, 1980